CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects. [electronic resource]
Producer: 20081021Description: 205-7 p. digitalISSN:- 1532-6535
- Adult
- Aged
- Anti-HIV Agents -- administration & dosage
- Antiretroviral Therapy, Highly Active
- Brazil
- Cytochrome P-450 CYP3A -- genetics
- Drug Therapy, Combination
- Genotype
- HIV Infections -- blood
- HIV Protease Inhibitors -- blood
- Humans
- Lopinavir
- Male
- Middle Aged
- Polymorphism, Genetic
- Pyrimidinones -- administration & dosage
- Ritonavir -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.